Safety and efficacy of oral calcitriol (1, 25 -dihydroxyvitamin D3) for the treatment of psoriasis
- 1 June 1996
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 134 (6) , 1070-1078
- https://doi.org/10.1111/j.1365-2133.1996.tb07945.x
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Active Vitamin D Compounds and Analogues: A New Therapeutic Era for Dermatology in the 21st CenturyMayo Clinic Proceedings, 1993
- Efficacy of Vitamin D3 Derivatives in the Treatment of Psoriasis Vulgaris: A Preliminary ReportMayo Clinic Proceedings, 1993
- A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney StonesNew England Journal of Medicine, 1993
- Methods for the determination of the circulating concentration of 25-hydroxyvitamin DThe Journal of Nutritional Biochemistry, 1990
- A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin DThe Journal of Nutritional Biochemistry, 1990
- Will 1,25-dihydroxyvitamin D3, MC 903, and their analogues herald a new pharmacologic era for the treatment of psoriasis?Archives of Dermatology, 1989
- Psoriasis and vitamin D3. A review of our experienceArchives of Dermatology, 1989
- Effect of 1α,25-Dihydroxyvitamin D3 on the Morphologic and Biochemical Differentiation of Cultured Human Epidermal Keratinocytes Grown in Serum-Free ConditionsJournal of Investigative Dermatology, 1986
- VITAMIN-D ANALOGUES AND RENAL FUNCTIONThe Lancet, 1978
- DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROLThe Lancet, 1978